Announcing

a Special Anniversary Rate for tct 2018!

For practicing physicians, academic researchers, and allied health professionals

30 Years of Groundbreaking Science, Training, and Innovation

SUBMISSION NOW CLOSED

Late-Breaking Clinical Trials are typically first-time international or US presentations of the primary endpoint or important secondary endpoint results of prospective, randomized clinical trials or of large-scale, impactful single-center or multicenter registries. TCT Late-Breaking Clinical Science submissions are the first worldwide presentations of smaller randomized trials, impactful single-center or multicenter registries, or first-in-man experiences with novel devices or drugs.

Accepted submissions will be presented in the Main Arena and during press conferences scheduled on the same days as the Main Arena presentations. The following rarely qualify as Late-Breaking Clinical Trial submissions: pre-clinical studies, early first-in-human device studies, and meta-analyses; these should be submitted as Abstracts or as Interventional Innovations.

If you have questions or need clarification, please email